Literature DB >> 9433029

Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.

J C Roujeau1.   

Abstract

A new classification, based on the pattern and distribution of cutaneous lesions, separates erythema multiforme major from Stevens-Johnson syndrome. A retrospective re-classification of 76 cases supported the validity of that separation by demonstrating differing causes and pathology. Another prospective international case-control study found differing demographic characteristics and risk factors between erythema multiforme major on the one hand and Stevens-Johnson syndrome or toxic epidermal necrolysis on the other. Erythema multiforme major was mainly related to Herpes virus infection, while Stevens-Johnson syndrome and toxic epidermal necrolysis were associated with drug reactions.

Entities:  

Mesh:

Year:  1997        PMID: 9433029     DOI: 10.1111/j.1346-8138.1997.tb02524.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  30 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

2.  Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.

Authors:  Lois La Grenade; Lauren Lee; Joyce Weaver; Renan Bonnel; Claudia Karwoski; Laura Governale; Allen Brinker
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Mutant GNLY is linked to Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Dora Janeth Fonseca; Luz Adriana Caro; Diana Carolina Sierra-Díaz; Carlos Serrano-Reyes; Olga Londoño; Yohjana Carolina Suárez; Heidi Eliana Mateus; David Bolívar-Salazar; Ana Francisca Ramírez; Alejandra de-la-Torre; Paul Laissue
Journal:  Hum Genet       Date:  2019-10-14       Impact factor: 4.132

4.  Early surgical correction of microstomia following Stevens-Johnson syndrome.

Authors:  Sae Hwi Ki; Gang Yeon Jo; Sung Hwan Ma; Matthew Seung Suk Choi
Journal:  Arch Craniofac Surg       Date:  2020-04-20

Review 5.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

6.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

7.  Stevens-Johnson syndrome and abuse of anabolic steroids.

Authors:  Serena Cocca; Massimo Viviano
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-02-20

Review 8.  Drug-induced skin, nail and hair disorders.

Authors:  Laurence Valeyrie-Allanore; Bruno Sassolas; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

10.  Oral lesions associated with nevirapine-related Stevens Johnson syndrome: A report of four cases.

Authors:  S Balasundaram; K Ranganathan; K Umadevi; R Gunaseelan; N Kumaraswamy; Sunithi Solomon; Bella Devaleenol; Pradeep Ambrose
Journal:  J Oral Maxillofac Pathol       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.